Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cannabis for Spasticity in MS
NCT00260741Phase 2Terminated
- Start
- Mar 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cannabis in multiple sclerosis (MS). Started Mar 2003; status: terminated.
02
Drugs
cannabis
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT00260741.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00260741.